Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2021

Nov 15, 2021

BUY
$23.37 - $32.13 $51,414 - $70,686
2,200 Added 39.29%
7,800 $241,000
Q3 2018

Nov 14, 2018

SELL
$38.6 - $46.12 $598,300 - $714,860
-15,500 Closed
0 $0
Q2 2018

Aug 14, 2018

BUY
$40.56 - $51.36 $628,680 - $796,080
15,500 New
15,500 $638,000
Q3 2017

Nov 14, 2017

BUY
$49.16 - $54.45 $275,296 - $304,920
5,600
5,600 $285,000

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.88B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.